Literature DB >> 31087242

Nucleic Acid-Based Therapeutics Relevant to Neuroimmune Conditions.

Ariele L Greenfield1, Stephen L Hauser2.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31087242      PMCID： PMC6554460          DOI： 10.1007/s13311-019-00740-5

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN： 1878-7479            Impact factor:   7.620


× No keyword cloud information.
  26 in total

Review 1.  Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides.

Authors:  Richard S Geary; Daniel Norris; Rosie Yu; C Frank Bennett
Journal:  Adv Drug Deliv Rev       Date:  2015-02-07       Impact factor: 15.470

Review 2.  Developing therapeutic antibodies for neurodegenerative disease.

Authors:  Y Joy Yu; Ryan J Watts
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

3.  Central and peripheral administration of antisense oligonucleotide targeting amyloid-β protein precursor improves learning and memory and reduces neuroinflammatory cytokines in Tg2576 (AβPPswe) mice.

Authors:  Susan A Farr; Michelle A Erickson; Michael L Niehoff; William A Banks; John E Morley
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

4.  Characteristics and outcome of early-onset, severe forms of Wiskott-Aldrich syndrome.

Authors:  Nizar Mahlaoui; Isabelle Pellier; Cécile Mignot; Jean-Philippe Jais; Chrystèle Bilhou-Nabéra; Despina Moshous; Bénédicte Neven; Capucine Picard; Geneviève de Saint-Basile; Marina Cavazzana-Calvo; Stéphane Blanche; Alain Fischer
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

5.  Type 1 diabetes immunotherapy using polyclonal regulatory T cells.

Authors:  Jeffrey A Bluestone; Jane H Buckner; Mark Fitch; Stephen E Gitelman; Shipra Gupta; Marc K Hellerstein; Kevan C Herold; Angela Lares; Michael R Lee; Kelvin Li; Weihong Liu; S Alice Long; Lisa M Masiello; Vinh Nguyen; Amy L Putnam; Mary Rieck; Peter H Sayre; Qizhi Tang
Journal:  Sci Transl Med       Date:  2015-11-25       Impact factor: 17.956

6.  Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.

Authors:  Alessandro Aiuti; Luca Biasco; Samantha Scaramuzza; Francesca Ferrua; Maria Pia Cicalese; Cristina Baricordi; Francesca Dionisio; Andrea Calabria; Stefania Giannelli; Maria Carmina Castiello; Marita Bosticardo; Costanza Evangelio; Andrea Assanelli; Miriam Casiraghi; Sara Di Nunzio; Luciano Callegaro; Claudia Benati; Paolo Rizzardi; Danilo Pellin; Clelia Di Serio; Manfred Schmidt; Christof Von Kalle; Jason Gardner; Nalini Mehta; Victor Neduva; David J Dow; Anne Galy; Roberto Miniero; Andrea Finocchi; Ayse Metin; Pinaki P Banerjee; Jordan S Orange; Stefania Galimberti; Maria Grazia Valsecchi; Alessandra Biffi; Eugenio Montini; Anna Villa; Fabio Ciceri; Maria Grazia Roncarolo; Luigi Naldini
Journal:  Science       Date:  2013-07-11       Impact factor: 47.728

7.  CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.

Authors:  Moa Fransson; Elena Piras; Joachim Burman; Berith Nilsson; Magnus Essand; Binfeng Lu; Robert A Harris; Peetra U Magnusson; Eva Brittebo; Angelica S I Loskog
Journal:  J Neuroinflammation       Date:  2012-05-30       Impact factor: 8.322

8.  VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells.

Authors:  Tilman Schneider-Hohendorf; Jan Rossaint; Hema Mohan; Daniel Böning; Johanna Breuer; Tanja Kuhlmann; Catharina C Gross; Ken Flanagan; Lydia Sorokin; Dietmar Vestweber; Alexander Zarbock; Nicholas Schwab; Heinz Wiendl
Journal:  J Exp Med       Date:  2014-08-18       Impact factor: 14.307

9.  CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS.

Authors:  Volker Limmroth; Frederik Barkhof; Nuket Desem; Mark P Diamond; George Tachas
Journal:  Neurology       Date:  2014-09-19       Impact factor: 9.910

10.  Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.

Authors:  Alessandra Biffi; Eugenio Montini; Laura Lorioli; Martina Cesani; Francesca Fumagalli; Tiziana Plati; Cristina Baldoli; Sabata Martino; Andrea Calabria; Sabrina Canale; Fabrizio Benedicenti; Giuliana Vallanti; Luca Biasco; Simone Leo; Nabil Kabbara; Gianluigi Zanetti; William B Rizzo; Nalini A L Mehta; Maria Pia Cicalese; Miriam Casiraghi; Jaap J Boelens; Ubaldo Del Carro; David J Dow; Manfred Schmidt; Andrea Assanelli; Victor Neduva; Clelia Di Serio; Elia Stupka; Jason Gardner; Christof von Kalle; Claudio Bordignon; Fabio Ciceri; Attilio Rovelli; Maria Grazia Roncarolo; Alessandro Aiuti; Maria Sessa; Luigi Naldini
Journal:  Science       Date:  2013-07-11       Impact factor: 47.728
View more
  2 in total

1.  Nucleic Acid Therapeutics for Neurological Diseases.

Authors:  Jonathan K Watts; Robert H Brown; Anastasia Khvorova
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

2.  In vivo gene editing via homology-independent targeted integration for adrenoleukodystrophy treatment.

Authors:  Sung-Ah Hong; Jung Hwa Seo; Soohyun Wi; Eul Sik Jung; Jihyeon Yu; Gue-Ho Hwang; Ji Hea Yu; Ahreum Baek; Soeon Park; Sangsu Bae; Sung-Rae Cho
Journal:  Mol Ther       Date:  2021-05-29       Impact factor: 11.454
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.